The goal is to provide some guidance in selecting CRC-derived cell lines to study colorectal cancers in the context of GPX2 expression, specifically selection of certain cell lines to accomplish study of CRC types that tend to relapse and metastasize, avoiding use of cell lines with exceedingly low GPX2 levels. Here, GPX2 is linked to colorectal carcinoma.